SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%

SunTrust Robinson Humphrey Maintains Hold on Sage Therapeutics, Lowers Price Target to $35

SunTrust Robinson Humphrey maintains Sage Therapeutics (NASDAQ:SAGE) with a Hold and lowers the price target from $37 to $35.

Benzinga · 05/08/2020 15:26

SunTrust Robinson Humphrey maintains Sage Therapeutics (NASDAQ:SAGE) with a Hold and lowers the price target from $37 to $35.